Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1577631 | 0.74 | ALDH1A1 (0.35) | ALDH1A1TP53TSHR | |
| SCHEMBL31272081 | 0.73 | F2 (0.31) | ALDH1A1TP53TSHR | |
| SCHEMBL116271 | 0.72 | — | — | |
| SCHEMBL30995902 | 0.72 | ALDH1A1 (0.50) | ALDH1A1LMNAOR51E2TDP1TP53 | |
| SCHEMBL17077964 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL31092070 | 0.69 | — | — | |
| Ammonia Solution, Strong SCHEMBL21381330 | 0.69 | — | — | |
| SCHEMBL11002111 | 0.69 | — | — | |
| SCHEMBL31272238 | 0.67 | ALDH1A1 (0.30) | ALDH1A1TP53TSHR | |
| SCHEMBL31272417 | 0.67 | ALDH1A1 (0.30) | ALDH1A1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024248021-A1 | FILM-FORMING COMPOSITION, METHOD FOR PRODUCING SUBSTRATE, AND METHOD FOR PRODUCING FILM-FORMING COMPOSITION | セントラル硝子株式会社 | 2024-12-05 | — | — | WO | disclosed |
| US-20220096643-A1 | Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation | KODIAK SCIENCES INC (US) | 2022-03-31 | — | — | US | disclosed |
| EP-1988910-B1 | ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION | KODIAK SCIENCES INC (US) | 2017-12-06 | — | — | EP | disclosed |
| EP-3222142-A1 | ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION | Kodiak Sciences Inc. (US) | 2017-09-27 | — | — | EP | disclosed |
| US-20150050714-A1 | Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation | OLIGASIS, LLC (US) | 2015-02-19 | — | — | US | disclosed |
| US-8846021-B2 | Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation | OLIGASIS, LLC (US) | 2014-09-30 | — | — | US | disclosed |
| US-20130337534-A1 | Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation | OLIGASIS, LLC (US) | 2013-12-19 | — | — | US | disclosed |
| US-20100166700-A1 | Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation | OLIGASIS CORPORATION (US) | 2010-07-01 | — | — | US | disclosed |
| EP-1988910-A2 | ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION | Oligasis Corporation (US) | 2008-11-12 | — | — | EP | disclosed |
| WO-2007100905-A2 | ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION | NEXGEN THERAPEUTICS, LLC (US) | 2007-09-07 | — | — | WO | disclosed |
| WO-2007100902-A2 | ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION | OLIGASIS CORPORATION (US) | 2007-09-07 | — | — | WO | disclosed |
| CN-1053672-C | Azasteroid compounds for the treatment of prostatic hypertrophy | SANKYO CO (JP) | 2000-06-21 | — | — | CN | disclosed |
| CN-1062145-A | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | SANKYO CO (JP) | 1992-06-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100166700-A1 | Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation | PHOSPHO1, PCTP, SGMS1 | ALDH1A1 2399/4885LMNA 1276/4885OR51E2 3592/4885 |
| US-20220096643-A1 | Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation | PHOSPHO1, PCTP, SGMS1 | ALDH1A1 2399/4885LMNA 1276/4885OR51E2 3592/4885 |
| US-20130337534-A1 | Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation | PHOSPHO1, PCTP, SGMS1 | ALDH1A1 2399/4885LMNA 1276/4885OR51E2 3592/4885 |
| US-20150050714-A1 | Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation | PHOSPHO1, PCTP, SGMS1 | ALDH1A1 2399/4885LMNA 1276/4885OR51E2 3592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.